Smithtown, NY, United States of America

Philip V Felice

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of Philip V. Felice

Introduction

Philip V. Felice is an accomplished inventor based in Smithtown, NY, recognized for his significant contributions to pharmaceutical technologies. With a total of 13 patents to his name, Felice has established himself as a leading figure in the field, notably focusing on drug delivery systems and crystal engineering.

Latest Patents

Among his latest patents, Felice has developed a platform drug delivery system utilizing crystal engineering and theanine dissolution. This innovative approach enhances the delivery of low solubility pharmaceuticals, resulting in improved bioactivity, dissolution rate, and solid-state stability. Another noteworthy patent involves the characterization of co-crystal products formed by metoprolol and dabigatran bases with L-theanine, further showcasing his expertise in pharmaceutical compositions.

Career Highlights

Felice's career is highlighted by his role at Theaprin Pharmaceuticals Inc., where he continues to develop pioneering technologies aimed at addressing critical challenges in drug delivery and formulation. His patents reflect a commitment to advancing the field through innovative solutions that enhance therapeutic efficacy.

Collaborations

Collaboration plays a significant role in Felice's work, particularly with his coworker, Harry G. Brittain. This partnership has led to the development of groundbreaking research in crystal engineering and pharmaceutical formulations, significantly benefiting their collective projects.

Conclusion

Philip V. Felice stands out as a remarkable inventor whose innovative contributions continue to shape the landscape of pharmaceutical technologies. With an impressive portfolio of patents and collaborative projects, he remains at the forefront of developing solutions that enhance drug delivery systems for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…